Cargando…
GAP43, a novel metastasis promoter in non-small cell lung cancer
BACKGROUND: Brain metastasis is an extremely serious sequela with a dismal prognosis in non-small cell lung cancer (NSCLC). The present study aimed to identify novel biomarkers and potential therapeutic targets for brain metastases of NSCLC. METHODS: We performed high-throughput Luminex assays to pr...
Autores principales: | Zhang, Fanrong, Ying, Lisha, Jin, Jiaoyue, Feng, Jianguo, Chen, Kaiyan, Huang, Minran, Wu, Yingxue, Yu, Herbert, Su, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233536/ https://www.ncbi.nlm.nih.gov/pubmed/30419922 http://dx.doi.org/10.1186/s12967-018-1682-5 |
Ejemplares similares
-
Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma
por: Huang, Minran, et al.
Publicado: (2020) -
The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer
por: Zhang, Fanrong, et al.
Publicado: (2016) -
Complement component 7 (C7), a potential tumor suppressor, is correlated with tumor progression and prognosis
por: Ying, Lisha, et al.
Publicado: (2016) -
Regenerating Family Member 4 (Reg4) Enhances 5-Fluorouracil Resistance of Gastric Cancer Through Activating MAPK/Erk/Bim Signaling Pathway
por: Jin, Jiaoyue, et al.
Publicado: (2017) -
Oncogenic Alterations in Histologically Negative Lymph Nodes Are Associated with Prognosis of Patients with Stage I Lung Adenocarcinoma
por: Tian, Yiping, et al.
Publicado: (2022)